GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » Days Payable

Medical Developments International (ASX:MVP) Days Payable : 517.42 (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International Days Payable?

Medical Developments International's average Accounts Payable for the six months ended in Dec. 2023 was A$11.57 Mil. Medical Developments International's Cost of Goods Sold for the six months ended in Dec. 2023 was A$4.08 Mil. Hence, Medical Developments International's Days Payable for the six months ended in Dec. 2023 was 517.42.

The historical rank and industry rank for Medical Developments International's Days Payable or its related term are showing as below:

ASX:MVP' s Days Payable Range Over the Past 10 Years
Min: 79.9   Med: 128.85   Max: 451.49
Current: 451.49

During the past 13 years, Medical Developments International's highest Days Payable was 451.49. The lowest was 79.90. And the median was 128.85.

ASX:MVP's Days Payable is ranked better than
92.73% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.34 vs ASX:MVP: 451.49

Medical Developments International's Days Payable increased from Dec. 2022 (447.09) to Dec. 2023 (517.42). It may suggest that Medical Developments International delayed paying its suppliers.


Medical Developments International Days Payable Historical Data

The historical data trend for Medical Developments International's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International Days Payable Chart

Medical Developments International Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 111.62 142.05 211.18 229.68 333.42

Medical Developments International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.08 439.32 447.09 418.49 517.42

Competitive Comparison of Medical Developments International's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's Days Payable distribution charts can be found below:

* The bar in red indicates where Medical Developments International's Days Payable falls into.



Medical Developments International Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Medical Developments International's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

Days Payable (A: Jun. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jun. 2022 ) + Accounts Payable (A: Jun. 2023 )) / count ) / Cost of Goods Sold (A: Jun. 2023 )*Days in Period
=( (5.174 + 13.324) / 2 ) / 10.125*365
=9.249 / 10.125*365
=333.42

Medical Developments International's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (13.324 + 9.811) / 2 ) / 4.08*365 / 2
=11.5675 / 4.08*365 / 2
=517.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medical Developments International Days Payable Related Terms

Thank you for viewing the detailed overview of Medical Developments International's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Medical Developments International (ASX:MVP) Business Description

Traded in Other Exchanges
N/A
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International (ASX:MVP) Headlines

From GuruFocus

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire 03-18-2022